COMPLICATIONS OF DIABETIC RETINOPATHY AND THEIR SOLUTION
Keywords:
Диабетическая ретинопатия, витрэктомия, лазерAbstract
The paper provides an overview of modern methods of diagnosis and treatment of diabetic retinopathy and its complications. The advantages and disadvantages of individual treatment methods are listed. Indications and contraindications for specific types of treatment for diabetic retinopathy are described. Particular attention is paid to the surgical method of treatment, listing preoperative predictors of high or low functional and anatomical success. Brief summaries of each treatment method are provided.
References
Fong DS, Aiello AP, Ferris FL, Klein R. Diabetic retinopathy. Diabetes Care. 2004; 27:2540–53.
Candrilli SD, Davis KL, Kan HJ, Lucero MA, Rousculp MD. Prevalence and the associated burden of illness of symptoms of diabetic peripheral neuropathy and diabetic retinopathy. J Diabetes Complications. 2007; 21:306–14.
Porta M., Kohner E. Screening for diabetic retinopathy in Europe // Diabetic Med. – 1991. – Vol. 8. – № 3. – P. 197-198.
Gross JG, Glassman AR, Liu D, Diabetic Retinopathy Clinical Research Network, et al. Diabetic retinopathy clinical research network. Five-year outcomes of panretinal photocoagulation vs. intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial. JAMA Ophthalmol. 2018;136(10):1138–1148.
Colin TS, Kiong NW, Wong HK, Yang FP. New insights into diabetic retinopathy-risk factors for prevalence, incidence and progression in Asians. Annals of the Academy of Medicine Singapore 2012;41(9 Suppl 1): S111.
Two-year course of visual acuity in severe proliferative diabetic retinopathy with conventional management. Diabetic retinopathy vitrectomy study (DRVS) report #1. Ophthalmology. 1985; 92:492–502.
Mu Eliott D. Vitreoretinal Attachments in Proliferative Diabetic Retinopathy: Effect on Outcome. Vail Vitrectomy Meeting Vail, CO. 2004
Lakhanpal RR, Humayun MS, de Juan E, Jr, Lim JI, Chong LP, Chang TS. Outcomes of 140 consecutive cases of 25-gauge transconjunctival surgery for posterior segment disease. Ophthalmology. 2005; 112:817–24.
Berk Ergun S, Toklu Y, Cakmak HB, Raza S, Simsek S. The effect of intravitreal bevacizumab as a pretreatment of vitrectomy for diabetic vitreous hemorrhage on recurrent hemorrhage. Semin Ophthalmol. 2015; 30:177–80.
Mason JO, 3rd, Colagross CT, Haleman T, Fuller JJ, White MF, Feist RM, et al. Visual outcome and risk factors for light perception and no light perception vision after vitrectomy for diabetic retinopathy. Am J Ophthalmol. 2005; 140:231–5.
Sullu Y, Hamidova R, Beden U, Yakupov K, Canbaz S, Danaci M, et al. Effects of pars plana vitrectomy on retrobulbar haemodynamics in diabetic retinopathy. Clin Exp Ophthalmol. 2005; 33:246–51.
Charles S. Vitreous Microsurgery. Baltimore: Williams and Wilkins; 2002. pp. 107–20.
Lucke KH, Foerster MH, Laqua H. Long-term results of vitrectomy and silicone oil in 500 cases of complicated retinal detachments. Am J Ophthalmol. 1987; 104:624–33.
Brourman ND, Blumenkranz MS, Cox MS, Trese MT. Silicone oil for the treatment of severe proliferative diabetic retinopathy. Ophthalmology. 1989; 96:759–64.
Gonvers M. Temporary silicone oil tamponade in the treatment of complicated diabetic retinal detachments. Graefes Arch Clin Exp Ophthalmol. 1990; 228:415–22.
Eliott D, Lee MS, Abrams GW. Proliferative diabetic retinopathy: Principles and techniques of surgical treatment. In: Ryan SJ, editor. Retina. 4th ed. Amsterdam, The Netherlands: Elsevier Inc; 2006. pp. 2413–49.
Thompson JT, de Bustros S, Michels RG, Rice TA. Results and prognostic factors in vitrectomy for diabetic traction-rhegmatogenous retinal detachment. Arch Ophthalmol. 1987; 105:503–7.
Nakazawa M, Kimizuka Y, Watabe T, Kato K, Watanabe H, Yamanobe S, et al. Visual outcome after vitrectomy for diabetic retinopathy. A five-year follow-up. Acta Ophthalmol (Copenh) 1993; 71:219–23.
Dooley I, Laviers H, Papavasileiou E, Mckechnie C, Zambarakji H. Spectral domain ocular coherence tomography findings pre- and post vitrectomy with fibrovascular membrane delamination for proliferative diabetic retinopathy. Eye (Lond) 2016; 30:34–9.
Статья поступила в редакцию 12.03.2024; одобрена после рецензирования 20.04.2024; принята к публикации 26.04.2024.
The article was submitted 12.03.2024; approved after reviewing 20.04.2024; accepted for publication 26.04.2024.
Информация об авторах:
Юсупов Азамат Фархадович – д.м.н., профессор, Республиканский специализированный научно-практический медицинский центр микрохирургии глаза, Ташкент, Узбекистан, Email: info@eyecenter.uz, https://orcid.org/0000-0002-4462-5091, Tel (95)146-48-58
Хусанбаев Хасанжон Шавкатович - PhD, Республиканский специализированный научно-практический медицинский центр микрохирургии глаза, Ташкент, Узбекистан, Email: hasanjon77777@gmail.com, https://orcid.org/0000-0002-3171-8061
Абдуллаева Саида Ибрагимовна - PhD, Республиканский специализированный научно-практический медицинский центр микрохирургии глаза, Ташкент, Узбекистан, Email: info@eyecenter.uz https://orcid.org/ 0000-0003-1040-2866
Источники финансирования: Работа не имела специального финансирования.
Конфликт интересов: Авторы декларируют отсутствие явных и потенциальных конфликтов интересов, связанных с публикацией настоящей статьи.
Вклад авторов:
Юсупов А.Ф. — написание текста; редактирование статьи;
Хусанбаев Х.Ш. — сбор и анализ источников литературы, написание текста.
Абдуллаева С.И. – сбор материала
Information about the authors:
Yusupov Azamat Farkhadovich – Doctor of Medical Sciences, Professor, Republican Specialized Scientific and Practical Medical Center for Eye Microsurgery, Tashkent, Uzbekistan, Email: (hidden) https://orcid.org/0000-0002-4462-5091, Tel (95)146-48-58
Khusanbaev Khasanjon Shavkatovich - PhD, Republican Specialized Scientific and Practical Medical Center for Eye Microsurgery, Tashkent, Uzbekistan, Email: (hidden) https://orcid.org/0000-0002-3171-8061
Abdullaeva Saida Ibragimovna - PhD, Republican Specialized Scientific and Practical Medical Center for Eye Microsurgery, Tashkent, Uzbekistan, Email: (hidden) https://orcid.org/ 0000-0003-1040-2866
Sources of funding: The work did not have special funding.
Conflict of interest: The authors declare that there are no obvious or potential conflicts of interest related to the publication of this article.
Authors' contributions:
Yusupov A.F. — writing text; article editing;
Khusanbaev Kh.Sh. — collection and analysis of literature sources, writing text.
Abdullaeva S.I. – collection of material
